M&A Deal Summary |
|
---|---|
Date | 2004-09-29 |
Target | ev3 - Percutaneous Heart Valve Technology |
Sector | Business Services |
Buyer(s) | Edwards |
Sellers(s) | ev3 |
Deal Type | Divestiture |
Deal Value | 15M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1958 |
Sector | Medical Products |
Employees | 19,800 |
Revenue | 6.0B USD (2023) |
Edwards is focused on technologies that treat structural heart disease and critically ill patients. The Company is engaged in the development and commercialization of heart valve therapies. Edwards was founded in 1958 and is based in Irvine, California.
DEAL STATS | # |
---|---|
Overall | 5 of 15 |
Sector (Business Services) | 1 of 1 |
Type (Divestiture) | 3 of 5 |
State (Minnesota) | 1 of 1 |
Country (United States) | 3 of 11 |
Year (2004) | 1 of 1 |
Size (of disclosed) | 10 of 10 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2003-12-15 |
Percutaneous Valve Technologies
Fort Lee, New Jersey, United States Percutaneous Valve Technologies, Inc. is a privately held medical technology company developing an innovative, percutaneous approach for delivering heart valves to treat late-stage aortic stenosis. |
Buy | $125M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2006-12-04 |
Edwards Lifesciences - Angiogenesis Program
Irvine, California, United States Edwards Lifesciences Corp. - Angiogenesis Program provides life science reasearch on proprietary zinc finger protein (ZFP) platform. |
Sell | - |
Category | Company |
---|---|
Founded | 2000 |
Sector | Healthcare Services |
Employees | 1,350 |
ev3 is the endovascular technology company that brings together the right people, technology, and resources to successfully identify and provide meaningful clinical solutions to underserved markets in the endovascular field. ev3 has been dedicated to developing breakthrough and clinically proven technologies for the endovascular treatment of peripheral vascular and neurovascular diseases.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Business Services) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (Minnesota) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2004) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2006-01-06 |
Micro Therapeutics
Irvine, California, United States Micro Therapeutics is a develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of vascular disease. The company is focused on catheter-based, or endovascular, technologies for the minimally invasive treatment of neurovascular disorders of the brain associated with stroke. |
Buy | - |